News
How Wearable Injectors Are Transforming Large-Volume Drug Delivery
The pharmaceutical industry is continually evolving to improve patient care, treatment outcomes, and convenience. One of the most significant innovations in recent years is the development of wearable injectors, which are transforming the way large-volume medications are administered. These...
News
DMSO as a Solvent in Pharmacological Research: Benefits, Risks, and Handling Considerations
Dimethyl sulfoxide (DMSO) is one of the most widely used solvents in pharmacological research. Its ability to dissolve a broad range of organic compounds including many that are poorly soluble in aqueous media has made it a default choice...
Business & Industry
Insilico Medicine Advances ISM8969 Into Phase 1 Trial as Brain-Penetrant NLRP3 Inhibitor for Neuroinflammation
Insilico Medicine has reached a significant clinical milestone with the completion of first-in-human dosing of ISM8969 in a Phase 1 study. Conducted in collaboration with Hygtia Therapeutics, the ISM8969 Phase 1 trial marks the transition of this oral, brain-penetrant...
News
How Telehealth Care in New Hampshire Is Transforming Rural Healthcare
Access to quality healthcare remains a challenge for many people living in rural communities. Long travel distances, limited provider availability, and healthcare workforce shortages often make it difficult to receive timely medical attention. Fortunately, telehealth care in New Hampshire...
Business & Industry
Moderna Commercial Expansion Accelerates Vaccine Launches
Moderna is strengthening its commercial leadership and operational structure as it prepares for a series of anticipated vaccine launches over the next several years. The company expects potential introductions of its mRNA-based seasonal flu vaccine, combined flu/COVID-19 vaccine, and...
Business & Industry
Jazz AbCellera Alliance Targets Next-Generation Cancer Drugs
Jazz Pharma has entered into a major collaboration with AbCellera focused on advancing cancer immunotherapy programmes, signing an agreement that could ultimately exceed $4 billion in value. Under the arrangement, the companies will work on up to five multispecific...
Business & Industry
Alzheimer’s Drug Packaging Expansion Receives UK Funding
Eisai is moving ahead with a major upgrade of its manufacturing facility in Hatfield, Hertfordshire, backed by support from the United Kingdom’s Life Sciences Innovative Manufacturing Fund (LSIMF). The Japanese drugmaker is investing approximately 48 million pounds sterling ($64.5...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.